(R)-3-Amino-4-(5-(4-((5-methoxypyrimidin-2-yl)oxy)phenyl)-2H-tetrazol-2-yl)butanoic acid

ID: ALA4874303

PubChem CID: 164625897

Max Phase: Preclinical

Molecular Formula: C16H17N7O4

Molecular Weight: 371.36

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1cnc(Oc2ccc(-c3nnn(C[C@H](N)CC(=O)O)n3)cc2)nc1

Standard InChI:  InChI=1S/C16H17N7O4/c1-26-13-7-18-16(19-8-13)27-12-4-2-10(3-5-12)15-20-22-23(21-15)9-11(17)6-14(24)25/h2-5,7-8,11H,6,9,17H2,1H3,(H,24,25)/t11-/m1/s1

Standard InChI Key:  ZBZMVFMJBAUXKB-LLVKDONJSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   38.6377  -19.8230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6366  -20.6426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3446  -21.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0543  -20.6421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0514  -19.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3428  -19.4142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9285  -21.0506    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.7554  -19.4099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.5032  -19.7394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.0477  -19.1300    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.6364  -18.4238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.8378  -18.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.8607  -19.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3385  -18.5495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1516  -18.6318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.6294  -17.9689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4424  -18.0512    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.2942  -17.2236    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.0034  -17.8042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2211  -20.6415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2263  -19.8244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.5198  -19.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8108  -19.8234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8127  -20.6448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5199  -21.0502    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1028  -19.4152    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3953  -19.8242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
  5  8  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 14 19  1  6
  7 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4874303

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 371.36

Molecular Weight (Monoisotopic): 371.1342

AlogP: 0.73

#Rotatable Bonds: 8

Polar Surface Area: 151.16

Molecular Species: ZWITTERION

HBA: 10

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.50

CX Basic pKa: 9.94

CX LogP: -1.42

CX LogD: -1.42

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.58

Np Likeness Score: -1.28

References

1. Markert C, Thoma G, Srinivas H, Bollbuck B, Lüönd RM, Miltz W, Wälchli R, Wolf R, Hinrichs J, Bergsdorf C, Azzaoui K, Penno CA, Klein K, Wack N, Jäger P, Hasler F, Beerli C, Loetscher P, Dawson J, Wieczorek G, Numao S, Littlewood-Evans A, Röhn TA..  (2021)  Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A₄ Hydrolase.,  64  (4.0): [PMID:33592148] [10.1021/acs.jmedchem.0c01955]

Source

Source(1):

• Scientific Literature